SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2Qingtao Meng, Rui Chen, Jie Xu et al.|Nano Today|2022Cited by 10
Corrigendum to “SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2” [Nano Today 47 (2022) 101667]Qingtao Meng, Rui Chen, Jing Wang et al.|Nano Today|2024Cited by 0